Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1T48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,505
Award facts
- Contract value 100% obligated
- $32,504.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,504.90 to AmerisourceBergen Drug Corp for the supply of KEVZARA 200 MG/1.14 ML pen injections. The contract, awarded on January 7, 2026, with an ultimate completion date of January 8, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. KEVZARA (sarilumab) is a biologic immunosuppressant used in the treatment of rheumatoid arthritis, reflecting the company's role in delivering specialized pharmaceutical products across multiple therapeutic domains. The delivery order demonstrates the company's capability to fulfill federal healthcare requirements on an expedited timeline while competing in an open procurement environment. As the primary vendor under the DLA Troop Support Medical IDC, AmerisourceBergen continues to support global pharmaceutical supply needs for military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F1T48?
SPE2DR26F1T48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F1T48 worth?
The government has obligated $32,505 on SPE2DR26F1T48.
Is contract SPE2DR26F1T48 an order under another contract?
Yes. SPE2DR26F1T48 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T48 competed?
The extent of competition for SPE2DR26F1T48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award